Drug Trial Radar · NCT05501860
A Safety Study of of AG-920 Sterile Topical Ophthalmic Solution
Last checked: Nov 19, 2026Latest source record: Oct 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
249
Actual
Start
Jul 30, 2022
Primary completion
Dec 7, 2022
Study completion Dec 7, 2022
Sponsor
- Lead sponsor
- American Genomics, LLCIndustry
- Sponsor type
- Industry
- First posted
- Aug 16, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Supportive care
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A Phase 3, randomized, placebo-controlled, double-masked, parallel study in healthy subjects. It is designed to evaluate the ocular safety of a single topical ocular administration of AG-920 sterile topical ophthalmic solution compared to placebo..
Conditions
- Anesthesia, Local
Interventions
AG-920Drug
AG-920 Sterile Topical Ophthalmic Solution
PlaceboDrug
Placebo Sterile Topical Ophthalmic Solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment Emergent Adverse Events (TEAEs)Time frame: From Day 1 (treatment day) to 4 days following treatment day; 90 days following treatment for subjects participating in specular microscopy.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
American Genomics Site 1
Newport Beach, California
American Genomics Site 2
McAllen, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.